Snapshot

The Collaboration on Gene Therapies Global Pilot (CoGenT) pathway has been developed by the of United States.

This pathway can be used where new gene therapies.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Regional regulatory initiatives can help optimize the efficient use of an agency’s resources. The following countries participate in this initiative/pathway: Argentina Brazil Canada China EU-EMA Egypt Japan Jordan Mexico Saudi Arabia Singapore South Korea Switzerland Taiwan (Chinese Taipei) Turkey United Kingdom United States WHO